> top > docs > PMC:7243768 > spans > 4876-5419 > annotations

PMC:7243768 / 4876-5419 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
194 385-393 Species denotes patients Tax:9606
197 332-351 Chemical denotes angiotensin type II
198 406-414 Disease denotes COVID-19 MESH:C000657245
199 475-492 Disease denotes diabetes mellitus MESH:D003920
200 494-517 Disease denotes cardiovascular problems MESH:D002318
201 522-536 Disease denotes renal diseases MESH:D007674

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T34 136-141 Body_part denotes Heart http://purl.org/sig/ont/fma/fma7088
T35 163-168 Body_part denotes Heart http://purl.org/sig/ont/fma/fma7088
T36 459-464 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T13 136-141 Body_part denotes Heart http://purl.obolibrary.org/obo/UBERON_0000948
T14 163-168 Body_part denotes Heart http://purl.obolibrary.org/obo/UBERON_0000948
T15 459-464 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T63 163-176 Disease denotes Heart Failure http://purl.obolibrary.org/obo/MONDO_0005252
T64 406-414 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T65 454-473 Disease denotes high blood pressure http://purl.obolibrary.org/obo/MONDO_0005044
T66 475-492 Disease denotes diabetes mellitus http://purl.obolibrary.org/obo/MONDO_0005015
T67 522-536 Disease denotes renal diseases http://purl.obolibrary.org/obo/MONDO_0002118|http://purl.obolibrary.org/obo/MONDO_0005240

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T55 136-141 http://purl.obolibrary.org/obo/UBERON_0000948 denotes Heart
T56 136-141 http://purl.obolibrary.org/obo/UBERON_0007100 denotes Heart
T57 136-141 http://purl.obolibrary.org/obo/UBERON_0015228 denotes Heart
T58 136-141 http://www.ebi.ac.uk/efo/EFO_0000815 denotes Heart
T59 163-168 http://purl.obolibrary.org/obo/UBERON_0000948 denotes Heart
T60 163-168 http://purl.obolibrary.org/obo/UBERON_0007100 denotes Heart
T61 163-168 http://purl.obolibrary.org/obo/UBERON_0015228 denotes Heart
T62 163-168 http://www.ebi.ac.uk/efo/EFO_0000815 denotes Heart
T63 204-205 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T64 459-464 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T65 459-464 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T66 539-541 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T18 323-327 Chemical denotes ACEi http://purl.obolibrary.org/obo/CHEBI_35457
T19 332-343 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T20 349-351 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T34 0-543 Sentence denotes In response to the above statement, the European Society of Cardiology on March 13 and the American College of Cardiology, the American Heart Association, and the Heart Failure Society of America endowed a common statement on March 17 which mentioned that “since there is no scientific evidence behind ceasing the usage of ACEi and angiotensin type II receptor blockers (ARBs) for the patients affected by COVID-19 possessing other comorbidities such as high blood pressure, diabetes mellitus, cardiovascular problems and renal diseases” [11].

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T29 163-176 Phenotype denotes Heart Failure http://purl.obolibrary.org/obo/HP_0001635
T30 454-473 Phenotype denotes high blood pressure http://purl.obolibrary.org/obo/HP_0000822
T31 475-492 Phenotype denotes diabetes mellitus http://purl.obolibrary.org/obo/HP_0000819